Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 7:40 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–20 of 20 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Lung Transplant Surgery Clear all

Conditions: Cerebral Autoregulation Impairment, Postoperative Cognitive Dysfunction, Postoperative Delirium
Interventions: BrainProtect System, Standard perioperative management; Device · Procedure
Lead sponsor: Scienceforbrain, UAB; Industry
Eligibility: 18 Years to 69 Years
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Congenital Disorders
Interventions: Not listed
Lead sponsor: Children's Healthcare of Atlanta; Other
Eligibility: Up to 21 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Lung Injury, Pulmonary Complication
Interventions: Fraction of Inspired Oxygen; Other
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Cardio-pulmonary Bypass, Coronary Artery Bypass Graft
Interventions: pexelizumab; Drug
Lead sponsor: Alexion Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2002
U.S. locations: 168
States / cities: Birmingham, Alabama • Mobile, Alabama • Mesa, Arizona + 120 more

Conditions: Post-Surgical Pain, Chronic, Post-traumatic Pain, Chronic
Interventions: Peripheral Transcutaneous Magnetic Stimulation from MagVenture; Device
Lead sponsor: Florida International University; Other
Eligibility: 19 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Bloodloss, Surgical Procedures, Operative
Interventions: ecallantide, placebo; Drug
Lead sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA); Industry
Eligibility: 18 Years to 85 Years
Enrollment: 276 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 21
States / cities: Birmingham, Alabama • Montgomery, Alabama • Aurora, Colorado + 14 more

Conditions: Pulmonary Disease, Chronic Obstructive, Emphysema
Interventions: Not listed
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 35 Years to 90 Years
Enrollment: 802 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Heart Transplant Surgery, Lung Transplant Surgery
Interventions: iNO, iEPO; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 519 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Surgery, Pneumonia, Surgical Site Infection
Interventions: Continuous Sternal Block, Opioid based analgesia; Device · Drug
Lead sponsor: Halyard Health; Industry
Eligibility: 18 Years and older
Enrollment: 647 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 8
States / cities: Birmingham, Alabama • Newark, Delaware • Lexington, Kentucky + 5 more

Conditions: Blood Recovery
Interventions: Hand Wrung, ProCell Wrung; Procedure · Device
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 89 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Reflux, Gastroesophageal Reflux Disease (GERD)
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 16 Years and older
Enrollment: 647 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 3
States / cities: Baltimore, Maryland • Durham, North Carolina • Cleveland, Ohio

Conditions: Blood Recovery
Interventions: Hand Wrung, ProCell Wrung; Procedure · Device
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 89 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Sinusitis, Chronic
Interventions: Sinus surgery; Procedure
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 64 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Lung Transplant, Complications Surgical
Interventions: Tranexamic Acid, Saline (placebo); Drug · Other
Lead sponsor: Corewell Health West; Other
Eligibility: 18 Years and older
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Cholecystitis, Cholecystitis, Chronic, Chronic Calculous Cholecystitis, Primary Hyperparathyroidism, Sigmoid Colon Diverticulitis, Multinodular Goiter, Thyroid and Parathyroid Surgery
Interventions: Observational study of SWIR imaging device in surgery; Device
Lead sponsor: Cision Vision, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 6
States / cities: Palo Alto, California • Evanston, Illinois • Glenview, Illinois + 2 more

Conditions: Cardiac Perfusion
Interventions: del Nido solution, Blood-based cardioplegia; Other
Lead sponsor: Inova Health Care Services; Other
Eligibility: 19 Years to 79 Years
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Falls Church, Virginia

Conditions: Transplant; Failure, Heart, Heart Failure, Congestive, Lung Transplant Failure
Interventions: Not listed
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 168 participants
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Heart Failure
Interventions: Nitric Oxide, Prostacyclin; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Stanford, California

Conditions: Pulmonary Surgical Procedures
Interventions: 129Xe MRI, 133XE scintigraphy; Drug
Lead sponsor: Polarean, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Durham, North Carolina • Charlottesville, Virginia

Conditions: Chronic Rhinosinusitis
Interventions: Checklist introduction / Pause; Behavioral
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Portland, Oregon

Search by objective public record fields.

BrainProtect-guided, Real-time Cerebral Autoregulation Monitoring and Protection of Brain During Cardiac Surgery With Cardiopulmonary Bypass Requiring Heart-lung Machine

Pulmonary Resistance in Fontan Who Have Undergone Heart Transplantation

Intra-operative Fraction of Inspired Oxygen and Lung Injury in Coronary Artery Bypass Grafting Surgery

Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass

Uncovering the Mechanism of Pain Relief by Peripheral Transcutaneous Magnetic Stimulation

A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume

Evaluating the Effects of Surgical and Non-Surgical Treatment Options in People With Emphysema

Inhaled Selective Pulmonary Vasodilators for Advanced Heart Failure Therapies and Lung Transplantation Outcomes

Multicenter Infection Surveillance Study Following Open Heart Surgery

Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell): Delayed Impact

RESULT (REflux Surgery in Lung Transplantation) Preliminary Study Protocol

Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell)

Nasal and Peripheral Blood Biomarkers of CRS Patients Before and After Surgical Intervention

Protest Trial: TXA vs Saline

Shortwave Infrared Surgical Imaging Device Study

Del Nido Cardioplegia Randomized Trial

Utilizing Technology for Optimization of Pain Management and Mobilization in High Risk Cardiac Surgical ICU Patients

Inhaled Nitric Oxide and Inhaled Prostacyclin After Cardiac Surgery for Heart Transplant or LVAD Placement

Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Transplant

Surgery Checklist and Process Improvement Surrounding Endoscopic Sinus Surgery